Related Experiment Videos
[Modified neuroleptanalgesia with buprenorphine]
Anasthesie, Intensivtherapie, Notfallmedizin
|December 1, 1982
Summary
Buprenorphine can be an alternative to fentanyl in neuroleptanalgesia, offering comparable hemodynamic stability and stress hormone levels. This modification provides long-lasting analgesia, beneficial for specific surgeries, though its antagonist and half-life present challenges.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Neuroleptanalgesia is a common anesthetic technique.
- Fentanyl is a frequently used opioid in anesthesia.
- Exploring alternative opioids like buprenorphine is crucial for anesthetic modifications.
Purpose of the Study:
- To evaluate the efficacy and safety of buprenorphine as a substitute for fentanyl in neuroleptanalgesia.
- To compare hemodynamic responses, stress hormone secretion, and postoperative respiratory depression between fentanyl and buprenorphine anesthesia.
Main Methods:
- A modified neuroleptanalgesia technique using buprenorphine instead of fentanyl.
- Comparative analysis of hemodynamic parameters, antidiuretic hormone and cortisol levels, and respiratory function.
- Assessment of postoperative analgesia duration and potential adverse effects.
Main Results:
- No significant differences were observed in hemodynamics, stress hormone secretion (antidiuretic hormone, cortisol), or postoperative respiratory depression between the buprenorphine and fentanyl groups.
- Buprenorphine provided prolonged postoperative analgesia, which can be advantageous in certain surgical contexts.
- The lack of a potent buprenorphine antagonist and its longer half-life were noted as potential drawbacks.
Conclusions:
- Buprenorphine serves as a viable alternative to fentanyl in neuroleptanalgesia, offering similar safety profiles regarding hemodynamics and respiratory function.
- The extended analgesic effect of buprenorphine is a significant benefit for specific surgical procedures.
- Careful consideration of buprenorphine's pharmacokinetic properties, including its long half-life and limited antagonist availability, is necessary for optimal clinical application.